Menu

News & Insights

  • Clear

Attorney General Brown Announces $13 Million in Settlements with Seven Opioid Drug Manufacturers

Maryland AG Anthony Brown has announced settlements with seven opioid drug manufacturers including Alvogen, Amneal, Apotex, Hikma, Mylan, Sun, and Zydus. Maryland is expected to receive over $13 million from the multistate settlement. The AGs alleged that for decades these seven companies have manufactured and sold generic opioids including oxycodone, hydrocodone, and fentanyl patches throughout the U.S., and that each of…

Read More

FTC Files Amicus Brief in Pharmaceutical Antitrust Case

The FTC has filed an amicus brief in an antitrust case alleging that drug manufacturer Johnson & Johnson illegally maintained a monopoly through anticompetitive conduct. The brief argues that the Supreme Court precedent establishes that antitrust law is focused on the impact of anticompetitive conduct, not on the intent to harm competition. CareFirst of Maryland…

Read More

Illinois AG Pens Latest EpiPen Deal With Mylan

Illinois AG Kwame Raoul reached an $8.25 million settlement with Mylan Inc. resolving allegations that the company used anticompetitive tactics to monopolize the epinephrine auto-injector market and overcharge Illinois Medicaid and employee health benefits programs for EpiPens. According to the AG’s office, Mylan allegedly raised prices, delayed generic competition, forced consumers to buy two-packs instead…

Read More

State AGs Pen EpiPen Settlements With Mylan

Maryland AG Anthony Brown and North Carolina AG Jeff Jackson announced separate settlements with Mylan resolving allegations that the company used anticompetitive tactics to maintain EpiPen’s market dominance and drive up prices for the life-saving allergy medication. According to the AGs’ offices, Mylan allegedly suppressed generic competition through exclusionary contracts with pharmacy benefit managers, delayed…

Read More

Louisiana AG Reaches $45 Million Settlement with CVS over Alleged PBM Misconduct

Louisiana AG Liz Murrill reached a $45 million settlement with CVS Health Corp. and its pharmacy benefit manager (PBM) subsidiary to resolve three lawsuits alleging deceptive and anti-competitive practices that allegedly violated the Louisiana Unfair Trade Practices Act. According to the AG’s office, the settlement resolves allegations that CVS improperly used customer information to conduct…

Read More